2 Clinical Trials Of Experimental Ebola Vaccines Begin In Europe, Africa

Reuters: Two new trials of Ebola vaccines begin in Europe and Africa
“Two new Ebola vaccine trials began on Wednesday with volunteers in Britain, France, and Senegal getting ‘prime-boost’ immunizations developed by Bavarian Nordic, GlaxoSmithKline, and Johnson & Johnson…” (Kelland, 7/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.